コンテンツへスキップ
Merck
  • Clinicopathological significance of claspin overexpression and its association with spheroid formation in gastric cancer.

Clinicopathological significance of claspin overexpression and its association with spheroid formation in gastric cancer.

Human pathology (2018-09-22)
Go Kobayashi, Kazuhiro Sentani, Takuya Hattori, Yuji Yamamoto, Takeharu Imai, Naoya Sakamoto, Kazuya Kuraoka, Naohide Oue, Naomi Sasaki, Kiyomi Taniyama, Wataru Yasui
要旨

Gastric cancer (GC) is one of the leading causes of cancer-related death worldwide. Spheroid colony formation is a useful method to identify cancer stem cells (CSCs). The aim of this study was to identify a novel prognostic marker or therapeutic target for GC using a method to identify CSCs. We analyzed the microarray data in spheroid body-forming and parental cells and focused on the CLSPN gene because it is overexpressed in the spheroid body-forming cells in both the GC cell lines MKN-45 and MKN-74. Quantitative reverse-transcription polymerase chain reaction analysis revealed that CLSPN messenger RNA expression was up-regulated in GC cell lines MKN-45, MKN-74, and TMK-1. Immunohistochemistry of claspin showed that 94 (47%) of 203 GC cases were positive. Claspin-positive GC cases were associated with higher T and N grades, tumor stage, lymphatic invasion, and poor prognosis. In addition, claspin expression was coexpressed with CD44, human epidermal growth factor receptor type 2, and p53. CLSPN small interfering RNA treatment decreased GC cell proliferation and invasion. These results indicate that the expression of claspin might be a key regulator in the progression of GC and might play an important role in CSCs of GC.